Injection therapy for carpal tunnel syndrome: A systematic review and network meta-analysis of randomized controlled trials
PLOS ONE · 16.05.2024 · 19 (5) · e0303537
DOI: 10.1371/journal.pone.0303537 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 16.05.2024. Verfasst von Fu-An Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Carpal Tunnel Syndrome, Randomized Controlled Trials as Topic, Platelet-Rich Plasma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Various injectants are available for the treatment of carpal tunnel syndrome. This systematic review and network meta-analysis was conducted to investigate the effectiveness of different injection therapies in alleviating the symptoms of carpal tunnel syndrome. Various databases were searched for relevant studies from inception until May 10, 2023. Eligible studies were identified using the patient (P), intervention (I), comparison (C), and outcomes (O) model, which involved (P) participants with carpal tunnel syndrome, (I) an intervention based on injection therapy, (C) the use of placebo or another injectant as a control treatment, and (O) the measurement of clinical and electrodiagnostic outcomes of interest. A total of 18 studies were included in the analysis. The network meta-analysis revealed that platelet-rich plasma is effective in the treatment of carpal tunnel syndrome in terms of symptom and pain relief and functional improvement in both the short and long term, whereas steroids are effective only in the short term. Additionally, injections of dextrose solution may offer long-term pain relief as well as short- and long-term symptom alleviation and functional improvement. The study findings suggest that platelet-rich plasma should be used as the first-line treatment for carpal tunnel syndrome, with dextrose and steroids serving as alternative treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
- Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
- School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Department of General Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- School of Gerontology Health Management, College of Nursing, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Hung-Chou Chen
Zitieren
APA
Yang, F. A., Wang, H. Y., Kuo, T. Y., Peng, C. W., Liou, T. H., Escorpizo, R., & Chen, H. C. (2024). Injection therapy for carpal tunnel syndrome: A systematic review and network meta-analysis of randomized controlled trials. PLOS ONE, 19(5), e0303537. https://doi.org/10.1371/journal.pone.0303537
Vancouver
Yang FA, Wang HY, Kuo TY, Peng CW, Liou TH, Escorpizo R, et al. Injection therapy for carpal tunnel syndrome: A systematic review and network meta-analysis of randomized controlled trials. PLOS ONE. 2024;19(5):e0303537. doi:10.1371/journal.pone.0303537
BibTeX
@article{Yang2024,
author = {Yang, Fu-An and Wang, Hsun-Yi and Kuo, Tien-Yu and Peng, Chih-Wei and Liou, Tsan-Hon and Escorpizo, Reuben and Chen, Hung-Chou},
title = {Injection therapy for carpal tunnel syndrome: A systematic review and network meta-analysis of randomized controlled trials},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {5},
pages = {e0303537},
doi = {10.1371/journal.pone.0303537}
}
EUVIMED